BPC-157
Pathway Genes
Biomeme does not prescribe, supply, recommend or evaluate this therapy. This page describes which genes it acts on, not whether you should take it.
There are no published human clinical trials of this peptide.
BPC-157 is a synthetic peptide studied in animal models of tissue injury. This page describes the genes those studies implicate and what a transcript panel can and cannot say about them.
Tracked Physiological Dimensions
On the Advanced Transcriptomics Dashboard, BPC-157 is tracked across three primary biological dimensions.
Oxidative Stress Response
Reports transcription of SOD1 and SOD2.
Cellular Stress Signaling
Tracks endoplasmic reticulum stress and heat shock response stabilization as recovery progresses.
Musculoskeletal Integrity & Recovery
Reports myogenic transcripts. These are skeletal-muscle genes and are not recoverable at meaningful abundance from a blood draw.
Tissue Repair Gene Regulation
In animal models, BPC-157 has been associated with changes in angiogenic and matrix gene expression.
This panel reports the transcription of EGR1, VEGFA, NOS3, SOD1 and SOD2. It does not identify responders, and it cannot inform dosing.
Key Target Genes
Vascular Endothelial Growth Factor A Angiogenesis
Growth factor driving new blood vessel formation.
Endothelial Nitric Oxide Synthase Vasodilation & Migration
Drives nitric oxide synthesis, essential for vascular tone and endothelial cell migration.
Early Growth Response 1 Fibroblast Proliferation
Triggers collagen synthesis and extracellular matrix deposition in tendon and muscle fibroblasts.
Superoxide Dismutase 1 & 2 Antioxidant Defense
Scavenges reactive oxygen species (ROS) to protect healing tissues from oxidative damage.
The Biomeme Molecular Ecosystem
From deep whole-transcriptome sequencing in the laboratory to rapid point-of-care instrumentation in the field.
High-Depth RNA Sequencing
Processed at One Health Labs, Biomeme's CLIA-certified laboratory, using Illumina NovaSeq high-depth paired-end RNA sequencing. Samples are collected in venous PAXgene blood RNA tubes to stabilize cellular transcription at the moment of draw.
Biomeme/5 Handheld Platform
Beyond central-lab genomics, Biomeme engineers patented, battery-powered real-time PCR instruments. Our deployable hardware brings decentralized molecular detection directly to the field and clinical points of care.
Curious how we measure this?
Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.
Ready to Learn More?
Explore how Biomeme's capabilities are being deployed across the Wellness landscape.
ABOUT THESE PANELS
Biomeme's wellness transcriptomic panels are general wellness products. They report gene activity to support a healthy lifestyle. They are not intended to diagnose, treat, cure, mitigate or prevent any disease or condition, and they are not a substitute for evaluation by a licensed healthcare professional. Results describe the state of the measured transcripts at the moment the sample was taken.